Cargando…

Influenza

Influenza continues to baffle humans by its constantly changing nature. The twenty-first century has witnessed considerable advances in the understanding of the influenza viral pathogenesis, its synergy with bacterial infections and diagnostic methods. However, challenges continue: to find a less ex...

Descripción completa

Detalles Bibliográficos
Autor principal: Dharmapalan, Dhanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091034/
https://www.ncbi.nlm.nih.gov/pubmed/32048225
http://dx.doi.org/10.1007/s12098-020-03214-1
_version_ 1783509980038561792
author Dharmapalan, Dhanya
author_facet Dharmapalan, Dhanya
author_sort Dharmapalan, Dhanya
collection PubMed
description Influenza continues to baffle humans by its constantly changing nature. The twenty-first century has witnessed considerable advances in the understanding of the influenza viral pathogenesis, its synergy with bacterial infections and diagnostic methods. However, challenges continue: to find a less expensive and more reliable point-of-care test for use in developing countries, to produce more efficacious antiviral drugs, to explore ways to combat emerging antiviral resistance and to develop vaccines that can either be produced in a shorter production time or can overcome the need for annual matching with the circulating influenza strains. Most importantly for India, as a nation that suffered the highest mortality in the influenza pandemic 1918, there is an urgent need to gear up our existing preparedness for the next pandemic which is capable to hit at any moment in time.
format Online
Article
Text
id pubmed-7091034
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-70910342020-03-24 Influenza Dharmapalan, Dhanya Indian J Pediatr Review Article Influenza continues to baffle humans by its constantly changing nature. The twenty-first century has witnessed considerable advances in the understanding of the influenza viral pathogenesis, its synergy with bacterial infections and diagnostic methods. However, challenges continue: to find a less expensive and more reliable point-of-care test for use in developing countries, to produce more efficacious antiviral drugs, to explore ways to combat emerging antiviral resistance and to develop vaccines that can either be produced in a shorter production time or can overcome the need for annual matching with the circulating influenza strains. Most importantly for India, as a nation that suffered the highest mortality in the influenza pandemic 1918, there is an urgent need to gear up our existing preparedness for the next pandemic which is capable to hit at any moment in time. Springer India 2020-02-11 2020 /pmc/articles/PMC7091034/ /pubmed/32048225 http://dx.doi.org/10.1007/s12098-020-03214-1 Text en © Dr. K C Chaudhuri Foundation 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Dharmapalan, Dhanya
Influenza
title Influenza
title_full Influenza
title_fullStr Influenza
title_full_unstemmed Influenza
title_short Influenza
title_sort influenza
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091034/
https://www.ncbi.nlm.nih.gov/pubmed/32048225
http://dx.doi.org/10.1007/s12098-020-03214-1
work_keys_str_mv AT dharmapalandhanya influenza